IMMUTEP LIMITED — Director's Dealing 2013

Jun 18, 2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR) ACN:[90 009 237 889 ]

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Martin Rogers

Date of Last Notice: 17.05.2013

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

`		Indirect	Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Ordinary Shares held in the names of director related entity, Structure Investments Pty Ltd (Rogers Family A/c)
Date of change		18 June 2013
No. of securities held prior to change				Options - 10,000,000 10,000,000
			Shares	Options
		Direct	-	-
		Indirect	20,542,179	10,000,000
		Total	20,542,179	10,000,000
Class		Listed options
Number acquired				Options - 2,500,000 2,500,000
			Shares	Options
		Direct	-	-
		Indirect	-	2,500,000
		**Total **	-	2,500,000

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

==> picture [419 x 255] intentionally omitted <==

----- Start of picture text -----

Number disposed
N/A
Value/Consideration
AUD 50,000
Note: If consideration is non-cash, provide details and
estimated valuation
No. of securities held after change
Shares Options
Direct - -
Indirect 20,542,179 12,500,000
Total 20,542,179 12,500,000
Nature of change
Acquiring 2,500,000 listed options at AUD 0.02
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment each
plan, participation in buy-back
----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [412 x 221] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
----- End of picture text -----

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above traded No during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?

19.06.2013

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002